ACTIVITY 3: TROPICAL INFECTIOUS DISEASES DETECTION AND PREVENTION

这个子项目是众多研究子项目之一

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Regarding AIDS: Tropical infectious diseases are among the most important public health problems facing most countries in the Asia-Pacific Region, and pose a major cause of morbidity and mortality, as well as crippling economic loss. The Tropical Infectious Diseases Detection and Prevention Core (TIDDPC) is an integral component of the Asia-Pacific Institute of Tropical Medicine and Infectious Diseases (APITMID), which provides a much-needed additional resource to help build a vigorous clinical and translational science program, focusing on developing improved diagnostic tests, rapid and accurate disease-detection systems, innovative treatments, vaccines and other prevention tools and strategies. The central hypothesis is that globalization and modern transportation, combined with demographic and societal changes in Asian countries, will result in more zoonotic disease agents jumping species and causing increasingly frequent outbreaks of diseases having potential of pandemic spread. Thus the establishment of research pre-eminence in tropical infectious diseases as UHM would provide a valuable link in an early-warning sentinel network for the continental United States on new, emerging and re-emerging infectious diseases. The specific aims of this RCMI-funded research core are to 1) develop a Pathogen Reference and Reagent Core Facility to support basic and applied research on new, emerging and re-emerging tropical infectious diseases; 2) develop a Molecular Pathology and Histology Core Facility to support research on new detection methods and pathogenesis of infectious diseases; and 3) develop a Microarray Core Facility to support pathogenesis-related research and assist in developing rapid pathogen-detection and pathogen-discovery technology.